surmount 1 tirzepatide SURPASS to SURMOUNT: The Trials To Know Gastrointestinal tolerability and weight reduction

Overlaps with other main groups are pronounced due to the broad therapeutic range, visible already in redundant titles like antibiotics and chemotherapeutics (D06) or corticosteroids (D07) (Table 2 and S1)

The Right Starting Point The trial data is compelling

Images are from the abstract, with the final image being from the original BELIEVE publication showing the 48 week data (rather than the 72)

A randomized controlled trial using a fractional factorial design showed that compared with placebo, the combined supplementation with riboflavin (3 mg/day) and niacin (40 mg/day) for five to six years reduced the prevalence of nuclear cataract but increased the progression of posterior subcapsular cataracts in population affected by multiple nutrient deficiency living in rural China (38)